Healthcare and Life Science
Strategies for combination therapy in oncology: Part one – Business as usual
This is the first in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In this article, we discuss the challenges and opportunities within the current landscape and key issues impacting pricing and access for comb...
Strategies for combination therapy in oncology: Part two - Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their c...
Antimicrobial Resistance Policy Solutions
It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments over the last 150 years, once life-threatening bacterial encounters have been relegated to minor inconveniences. Or have they? T...
PlaqueTec recruits first ten patients in BIOPATTERN trial
Cambridge, UK: PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), announces that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial foll...
Get to know the inflammatory bowel disease (IBD) team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Inflammatory Bowel Disease (IBD) team one of the core cogs in the workings of the NIHR BioResource! ...
Reflecting on our campaign to increase volunteer diversity
NIHR BioResource for Translational Research writes...As our 12-week campaign with Egality Health and eight community-based health advocacy organisations has come to a close, we’re reflecting on our successes and sharing some key learnings going forward. We also heard from some of our co...
Are employers responsible for the sick leave of workers they've sponsored?
Immigration lawyer Julie Moktadir says the demands of the health and care sector often sees employers asking questions in respect of sponsored workers. ...
Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema
Cambridgeshire and Nottingham, UK, 28 November 2023: Exonate Ltd., an mRNA therapy company focused on treatments for diabetic complications, announces its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in a phase Ib/IIa study. ...
UK falling behind rest of the world on realising value from new technology - Deloitte
New research from Deloitte reveals the top barriers to implementing and monetising digital technologies such as Cloud, AI and machine learning; Three-quarters of UK organisations believe that digital transformation is the single most important investment they can make; But, 30% of UK ...
Still time for agri and food-tech businesses to apply for innovation grants of up to £300,000
There is still time for businesses in the agri-tech, agri-biotech and food-tech sectors to apply for grants and support to boost innovation and growth. ...